Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Extensive-stage Small Cell Lung Cancer (ES-SCLC)”

138 trials

Showing 20 of 138 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07022301
What this trial is testing

Sintilimab Plus Anlotinib as Second or Further-line Therapy for ES-SCLC Who Have Progressed After Anti-PD-1/L1 Therapy

Who this might be right for
Small Cell Lung Cancer Extensive StageResistance to Immunotherapy
First Affiliated Hospital of Wannan Medical College 25
Testing effectiveness (Phase 2)Looking for participantsNCT06362252
What this trial is testing

I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)

Who this might be right for
Extensive Stage-small Cell Lung Cancer
Daiichi Sankyo 123
Testing effectiveness (Phase 2)UnknownNCT04683198
What this trial is testing

Camrelizumab Combined With Apatinib ,Carboplatin and Etoposide in Participants With ES-SCLC

Who this might be right for
Small-cell Lung Cancer
Chinese Academy of Medical Sciences 69
Testing effectiveness (Phase 2)Looking for participantsNCT06663098
What this trial is testing

Atezolizumab and Rechallenge Chemotherapy in Relapsed Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC).

Who this might be right for
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Gruppo Oncologico Italiano di Ricerca Clinica 142
Testing effectiveness (Phase 2)UnknownNCT03700359
What this trial is testing

Lobaplatin/Etoposide With or Without Anlotinib Maintenance Therapy in Patients With ES-SCLC

Who this might be right for
Small Cell Lung Carcinoma
The First Affiliated Hospital of Guangzhou Medical University 60
Large-scale testing (Phase 3)Looking for participantsNCT06712355
What this trial is testing

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Who this might be right for
Extensive-stage Small-cell Lung Cancer
BioNTech SE 621
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05703997
What this trial is testing

FASTing-like Approach and Maintenance IMMunotherapy in ES-SCLC Patients Not Progressing on Chemoimmunotherapy Induction

Who this might be right for
Small Cell Lung Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 20
Testing effectiveness (Phase 2)Looking for participantsNCT06429696
What this trial is testing

PD-L1 Inhibitor Combined With Apatinib as First-line Maintenance Treatment for Extensive-stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Nanfang Hospital, Southern Medical University 40
Testing effectiveness (Phase 2)Looking for participantsNCT06812260
What this trial is testing

A Single-arm, Open-label, Phase II Study to Evaluate Efficacy, Safety and Pharmacokinetics of HLX10 + Chemotherapy in Patients With ES-SCLC

Who this might be right for
SCLC, Extensive Stage
Shanghai Henlius Biotech 26
Testing effectiveness (Phase 2)Looking for participantsNCT05731518
What this trial is testing

SC0245 and Irinotecan in Treating Patients With Relapsed Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Who this might be right for
Small Cell Lung Cancer
Biocity Biopharmaceutics Co., Ltd. 67
Testing effectiveness (Phase 2)UnknownNCT05228496
What this trial is testing

Investigate the Efficacy and Safety of Tislelizumab Combined With Sitravatinib as Maintenance Therapy for ES-SCLC

Who this might be right for
Lung Cancer, Small Cell
Zhejiang Cancer Hospital 21
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06597513
What this trial is testing

Auto-HSCT-Supported Dose-Dense Chemotherapy with Adebrelimab As First-Line Treatment for ES-SCLC

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Zhou Chengzhi 10
Early research (Phase 1)Active Not RecruitingNCT05361395
What this trial is testing

First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Amgen 184
Testing effectiveness (Phase 2)Study completedNCT04924101
What this trial is testing

Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99)

Who this might be right for
Small Cell Lung Cancer
Merck Sharp & Dohme LLC 126
Testing effectiveness (Phase 2)Active Not RecruitingNCT05280470
What this trial is testing

Ifinatamab Deruxtecan (I-DXd) in Subjects With Pretreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Daiichi Sankyo 187
Large-scale testing (Phase 3)Not Yet RecruitingNCT06672133
What this trial is testing

Adebrelimab Combined with Chemotherapy and Thoracic Radiotherapy for First-line Treatment of ES-SCLC

Who this might be right for
Extensive Stage Lung Small Cell Carcinoma
Jinming Yu 524
Testing effectiveness (Phase 2)Looking for participantsNCT06217757
What this trial is testing

Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC

Who this might be right for
Lung CancerExtensive-stage Small-cell Lung Cancer
Sichuan University 45
Not applicableUnknownNCT04663438
What this trial is testing

Real World Study of Efficacy and Safety of Atezolizumab Plus Chemotherapy in Chinese Patients With ES-SCLC

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Peking Union Medical College Hospital 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06478043
What this trial is testing

Investigate the Efficacy and Safety of Ivonescimab Combined With Irinotecan Liposome as Second-line Regimen for ES-SCLC

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Zhejiang Cancer Hospital 54
Testing effectiveness (Phase 2)Study completedNCT00388960
What this trial is testing

Study of Amrubicin With or Without Cisplatin Versus Etoposide-cisplatin for Extensive Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Celgene 99
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation